GALLAGHER, MICHELA,HABERMAN, REBECCA,KOH, MING TENG
申请号：
CA2740610
公开号：
CA2740610C
申请日:
2009.10.16
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
This invention relatesto treating age-related cognitive im-pairment.This invention in particularrelates to the use of inhibitors ofsynaptic vesicle protein 2A (SV2A),such as levetiracetam, seletracetam,and brivaracetam, in improving cog-nitivefunction in subjects that exhib-itage-related cognitive impairmentor are at risk thereof, including, with-outlimitation, subjects having or atrisk for Mild Cognitive Impairment(MCI), Age-related Cognitive De-cline(ARCD) or Age-AssociatedMemory Impairment (AAMI).
